![]() | Robin John PrescottUsher Institute, University of Edinburgh, UK. | Centre for Population Health Sciences, Usher Institute, University of Edinburgh, UK | Centre for Population Health Sciences, ... |
KOL Resume for Robin John Prescott
Year | |
---|---|
2022 | Usher Institute, University of Edinburgh, UK. |
2020 | Centre for Population Health Sciences, Usher Institute, University of Edinburgh, UK |
2019 | Centre for Population Health Studies, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland, UK |
2016 | Usher Institute, University of Edinburgh, Edinburgh, UK |
2013 | Emeritus Professor of Health Technology Assessment, Edinburgh University, UK |
2012 | From the Department of Hematology/Transfusion Medicine, John Radcliffe Hospital, NHS Blood & Transplant/Oxford University Hospitals NHS Trust, Oxford; the Department of Critical Care, Royal Infirmary of Edinburgh, Edinburgh; the Centre for Population Health Sciences, University of Edinburgh, Edinburgh; Better Blood Transfusion, Scottish National Blood Transfusion Service, Glasgow; and the Department of Critical Care, Guy's & St Thomas' NHS Foundation Trust, St Thomas's Hospital, London, UK. Centre for Population Health Sciences, University of Edinburgh, UK |
2011 | Ethnicity and Health Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, EH8 9AG, UK |
2010 | Centre for Population Health Sciences, University of Edinburgh, 20 West Richmond Street, Edinburgh, EH8 9DX, UK |
2009 | Medical Statistics Unit, Public Health Sciences, University of Edinburgh, UK |
2008 | Diabetic Department, Victoria Hospital, Kirkcaldy, Fife KY2 5AH, Scotland, UK Medical Statistics Unit, Public Health Services, Medical School, Edinburgh Western General Hospital |
2007 | Medical Statistics Unit, University of Edinburgh, UK. Department of Public Health Sciences, University of Edinburgh, Edinburgh |
2006 | Medical Statistics Unit, Public Health Sciences, University of Edinburgh, Edinburgh, UK University of Leeds, Leeds, United Kingdom. |
2005 | Gastro‐Intestinal Unit, Western General Hospital, Edinburgh, and Department of Social Medicine (Computer and Statistics Section), University of Edinburgh Bristol-Myers Squibb Company, New York, USA |
2004 | Department of Dermatology, Royal Infirmary of Edinburgh, Edinburgh EH3 9WY, U.K. *Medical Statistics Unit, University of Edinburgh, Edinburgh EH8 9AG, U.K Medical Statistics Unit, Edinburgh, Scotland, UK |
2003 | Medical Statistics Unit, Public Health Sciences, Edinburgh, UK London, United Kingdom; Richmond, Virginia; Edinburgh, United Kingdom; Los Angeles, California; Burbank, California; Pontefract, United Kingdom; Liverpool, United Kingdom; Stoke-on-Trent, United Kingdom Department of Cardiac Surgery, Royal Infirmary of Edinburgh |
2002 | Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, UK |
2001 | Western General Hospital, Edinburgh, UK |
2000 | Haemophilia Centres at Royal Infirmary, Edinburgh and Royal Infirmary and Yorkhill Children’s Hospital, Glasgow, and Medical Statistics Unit, University of Edinburgh, UK Simpson Memorial Maternity Pavilion, Edinburgh |
1999 | Medical Statistics Unit, University of Edinburgh, Medical School, Edinburgh EH8 9AG Department of Community Health Sciences, University of Edinburgh, Edinburgh, UK |
1998 | Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland, UK |
1997 | University Hospital, Nottingham, UK. ; for the Joint Vascular Research Group Department of Clinical Oncology, Western General Hospital, Edinburgh, EH4 2XU U.K. |
Robin John Prescott: Influence Statistics
Concept | World rank |
---|---|
major embolism endocarditis | #1 |
mcid fps | #1 |
hcv admission rate | #1 |
dressings single | #1 |
actual peak flow | #1 |
smoking green sputum | #1 |
acute stroke followup | #1 |
vasomotor selfassessment | #1 |
parental perceived outcome | #1 |
aspirin antioxidants patients | #1 |
corticosteroids colitis | #1 |
stomach diversion | #1 |
peecm methylprednisolone | #1 |
relationship nasal airway | #1 |
oxford talley | #1 |
dressings venous ulcers | #1 |
detectable breast disorder | #1 |
relationship chronic sputum | #1 |
initial treatment ponseti | #1 |
period haemophilia | #1 |
612 observations | #1 |
critical multicentre study | #1 |
promam | #1 |
reasonable mediumterm survival | #1 |
adult critical indications | #1 |
breast control patients | #1 |
numerical prognostic | #1 |
allergic vasomotor selfassessment | #1 |
diastron ntb | #1 |
methods 360 patients | #1 |
critical clinical indications | #1 |
death progressive | #1 |
n320 aspirin tablet | #1 |
vitro oxidative response | #1 |
vasomotor selfassessment allergic | #1 |
heartvalve replacement | #1 |
20 years difference | #1 |
participants cancer centre | #1 |
calibration rockall | #1 |
local recurrence age | #1 |
postural function proprioception | #1 |
node sample radiotherapy | #1 |
protein ammonium acetate | #1 |
flutter vrp1 device | #1 |
study period haemophilia | #1 |
treatment resistant warts | #1 |
veins aftercare | #1 |
stimulated roi rate | #1 |
80 pef | #1 |
intermittent claudication retinopathy | #1 |
Open the FULL List in Excel | |
Prominent publications by Robin John Prescott
BACKGROUND: Up to 60% of patients with Crohn's disease need intestinal resection within the first 10 years of diagnosis, and postoperative recurrence is common. We investigated whether mercaptopurine can prevent or delay postoperative clinical recurrence of Crohn's disease.
METHODS: We did a randomised, placebo-controlled, double-blind trial at 29 UK secondary and tertiary hospitals of patients (aged >16 years in Scotland or >18 years in England and Wales) who had a confirmed diagnosis ...
Known for Patients Placebo | Crohns Disease | Surgical Resection | Clinical Recurrence | Controlled Trial |
BACKGROUND: Medication errors are common in primary care and are associated with considerable risk of patient harm. We tested whether a pharmacist-led, information technology-based intervention was more effective than simple feedback in reducing the number of patients at risk of measures related to hazardous prescribing and inadequate blood-test monitoring of medicines 6 months after the intervention.
METHODS: In this pragmatic, cluster randomised trial general practices in the UK were ...
Known for Medication Errors | Controlled Trial | General Practices | 6 Months | Patients Risk |
OBJECTIVES: To evaluate the implementation and adoption of the NHS detailed care records service in "early adopter" hospitals in England.
DESIGN: Theoretically informed, longitudinal qualitative evaluation based on case studies.
SETTING: 12 "early adopter" NHS acute hospitals and specialist care settings studied over two and a half years.
DATA SOURCES: Data were collected through in depth interviews, observations, and relevant documents relating directly to case study sites and to wider ...
Known for Health Records | Implementation Adoption | Early Adopter | Case Studies | Nhs Hospitals |
AIMS: Mortality in patients with heart failure remains high and is difficult to predict. QT interval parameters on a 12-lead ECG have been shown to predict arrhythmic events in patients with a variety of myocardial diseases. There is some, but not consistent, evidence that QT interval parameters may act as predictors of mortality, in particular sudden death, in patients with heart failure. In an adequately powered prospective study we have studied QT interval parameters in patients with ...
Known for Qt Intervals | Heart Failure | Sudden Death Patients | Allcause Mortality | Cardiac Electrocardiography |
PURPOSE: Patients with early breast cancer who receive anthracycline-containing chemotherapy experience improved relapse-free (RFS) and overall survival (OS) compared with those who receive non-anthracycline-containing chemotherapy. Such benefit, however, may be restricted to women whose tumors have specific molecular characteristics. We tested the hypothesis that HER2, epidermal growth factor receptor (EGFr)/HER1, HER3, Ki67, and topoisomerase IIalpha expression are predictive of ...
Known for Antineoplastic Antigens | Patients Her2 | Situ Hybridization | Adjuvant Breast | Cmf Rfs |
BACKGROUND: Medication errors are an important cause of morbidity and mortality in primary care. The aims of this study are to determine the effectiveness, cost effectiveness and acceptability of a pharmacist-led information-technology-based complex intervention compared with simple feedback in reducing proportions of patients at risk from potentially hazardous prescribing and medicines management in general (family) practice.
METHODS: RESEARCH SUBJECT GROUP: "At-risk" patients ...
Known for Simple Feedback | General Practices | Medicines Management | Pincer Trial | Cluster Randomised |
OBJECTIVES: To assess whether omission of postoperative radiotherapy in women with 'low-risk' axillary node negative breast cancer (T0-2) treated by breast-conserving surgery and endocrine therapy improves quality of life and is more cost-effective.
DESIGN: A randomised controlled clinical trial, using a method of minimisation balanced by centre, grade of cancer, age, lymphatic/vascular invasion and preoperative endocrine therapy, was performed. A non-randomised cohort was also ...
Known for Quality Life | Randomised Controlled Trial | Omission Radiotherapy | Endocrine Therapy | Conserving Surgery |
A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma
[ PUBLICATION ]
BACKGROUND: Current guidelines for the surgical management of melanoma aim to bring a combined consensus approach to the surgery of melanoma. Whether different outcomes for melanoma are related to the specialist who treats the patient is unknown.
OBJECTIVES: To examine the clinicopathological features and surgical management of patients with primary cutaneous malignant melanoma treated by dermatologists, general surgeons, plastic surgeons and general practitioners (GPs). We also examined ...
Known for Cutaneous Melanoma | General Practitioners | Plastic Surgeons | Surgical Treatment | Followup Patients |
OBJECTIVE: To determine whether aspirin and antioxidant therapy, combined or alone, are more effective than placebo in reducing the development of cardiovascular events in patients with diabetes mellitus and asymptomatic peripheral arterial disease.
DESIGN: Multicentre, randomised, double blind, 2x2 factorial, placebo controlled trial.
SETTING: 16 hospital centres in Scotland, supported by 188 primary care groups.
PARTICIPANTS: 1276 adults aged 40 or more with type 1 or type 2 diabetes ...
Known for Arterial Disease | Aspirin Groups | Controlled Trial | Asymptomatic Peripheral | Randomised Placebo |
Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial
[ PUBLICATION ]
BACKGROUND: In the treatment of operable breast cancer by breast conservation, the extent of axillary dissection, the need for radiotherapy to the axilla and the morbidity associated with these procedures have not been assessed adequately.
METHODS: Patients with operable breast cancer were randomized to have level III axillary node clearance (232 patients) or axillary node sample (234 patients). Radiotherapy to the axilla was given selectively. Radiotherapy was not given to those who had ...
Known for Operable Breast Cancer | Radiotherapy Axilla | Patients Node | Breast Conservation | 3 Years |
Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test
[ PUBLICATION ]
OBJECTIVE: To determine the uptake and acceptability of different methods of a universal offer of voluntary HIV testing to pregnant women.
DESIGN: Randomised controlled trial involving four combinations of written and verbal communication, followed by the direct offer of a test. The control group received no information and no direct offer of a test, although testing was available on request.
SETTING: Hospital antenatal clinic covering most of the population of the city of ...
Known for Hiv Test | Pregnant Women | Health Patient | Universal Offer | Maternity Humans |
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
[ PUBLICATION ]
OBJECTIVE: To determine the optimum duration of oral anticoagulant therapy after an episode of deep vein thrombosis or pulmonary embolism, or both.
DESIGN: Multicentre, prospective, randomised study with follow-up for one year.
SETTING: 46 hospitals in United Kingdom.
PARTICIPANTS: Patients aged > or =18 with deep vein thrombosis or pulmonary embolism, or both.
INTERVENTIONS: Three (n=369) or six months (n=380) of anticoagulation with heparin for five days accompanied and followed by ...
Known for Pulmonary Embolism | Deep Vein | Recurrence Treatment | Randomised Trial | Months Anticoagulation |
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure
[ PUBLICATION ]
OBJECTIVES: The aim of this study was to explore the value of noninvasive predictors of death/mode of death in ambulant outpatients with chronic heart failure (HF).
BACKGROUND: Mortality in chronic HF remains high, with a significant number of patients dying of progressive disease. Identification of these patients is important.
METHODS: We recruited 553 ambulant outpatients age 63 +/- 10 years with symptoms of chronic HF (New York Heart Association functional class, 2.3 +/- 0.5) and ...
Known for Chronic Heart | Progressive Hf | Serum Creatinine | Independent Predictors | Ventricular Dysfunction |
OBJECTIVES: To describe and evaluate the implementation and adoption of detailed electronic health records in secondary care in England and thereby provide early feedback for the ongoing local and national rollout of the NHS Care Records Service.
DESIGN: A mixed methods, longitudinal, multisite, socio-technical case study.
SETTING: Five NHS acute hospital and mental health trusts that have been the focus of early implementation efforts and at which interim data collection and analysis ...
Known for Electronic Health | Prospective National | Implementation Adoption | Qualitative Analysis | Nhs Records |
BACKGROUND: Glucocorticoids are associated with a reduction in bone density and an increased risk of fracture. Concurrent treatment with bisphosphonates reduces bone loss and may prevent fractures. A randomised study was performed to determine whether treatment with cyclical etidronate and/or calcium for 5 years prevents fractures or reverses/reduces bone loss in patients receiving glucocorticoid treatment for asthma.
METHODS: A multicentre, randomised, parallel group comparison of ...
Known for Patients Asthma | Inhalation Administration | Bone Loss | Lumbar Spine | Female Fractures |
Key People For Breast Cancer
Robin John Prescott:Expert Impact
Concepts for whichRobin John Prescotthas direct influence:Breast cancer, Pulmonary function, Ulcerative colitis, Controlled trial, Outreach workers, Operable breast cancer, Endoscopic therapy, Varicose veins.
Robin John Prescott:KOL impact
Concepts related to the work of other authors for whichfor which Robin John Prescott has influence:Breast cancer, Heart failure, Peripheral arterial disease, Aortic valve, Erectile dysfunction, Primary prevention, Diabetes mellitus.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |